
Novasep in €310m recap
French specialty chemicals company Novasep has completed its €310 recapitalisation, to which the FSI and Azulis Capital have contributed €33m in equity.
In addition to the FSI and Azulis Capital - which contributed €30m and and €3m respectively - Novasep's management team also received a "significant financial stake" in the business.
As reported by unquote" in November last year, Novasep was taken over by its lenders - which include US credit funds Tennenbaum, Silver Point and Pimco. Gilde relinquished its 46% stake in the business, reportedly recouping only €9m on the exit.
The GP, together with minority investor Azulis Capital, backed the €425m MBO of Novasep in 2006. The €310m debt package, which was arranged by ING and HVB, was largely bullet and included a large capex facility, some mezzanine and second lien debt.
The company breached a covenant on its loans in mid-2011. It previously refinanced the original debt structure by issuing a €375m equivalent euro/US dollar dual-tranche bond on the high-yield market in 2009.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater